Neuromodulation cryotherapeutic devices and associated systems and methods

US10842547B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10842547-B2
Application numberUS-201816221174-A
CountryUS
Kind codeB2
Filing dateDec 14, 2018
Priority dateOct 26, 2010
Publication dateNov 24, 2020
Grant dateNov 24, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state.

First claim

Opening claim text (preview).

We claim: 1. A cryotherapeutic device, comprising; an elongate shaft having a distal end portion, wherein the elongate shaft is configured to locate the distal end portion intravascularly at a treatment site within a renal artery or renal ostium; an exhaust passage extending along a length of the elongate shaft, wherein the exhaust passage is configured to carry gaseous refrigerant proximally along the length of the shaft; a supply lumen extending along the length of the elongate shaft, wherein the supply lumen is configured to carry liquid refrigerant distally along the length of the elongate shaft, and wherein the supply lumen includes— a helical portion that wraps around the exhaust passage at the distal end portion of the elongate shaft, and an orifice at the helical portion; and a cooling assembly at the distal end portion of the elongate shaft, wherein the cooling assembly has a low-profile delivery state and an expanded deployed state, and wherein the cooling assembly includes an applicator having a balloon with a wall, and wherein the applicator further comprises— a first heat-transfer portion configured to have a first heat-transfer rate while the cooling assembly is in the expanded deployed state and while the cooling assembly receives refrigerant via the supply lumen, wherein the orifice is configured to direct refrigerant from the supply lumen toward the first heat-transfer portion; and a second heat-transfer portion configured to have a second heat-transfer rate while the cooling assembly is in the expanded deployed state and while the cooling assembly receives refrigerant via the supply lumen, wherein the second heat-transfer rate is less than the first heat-transfer rate, wherein the first heat-transfer portion and second heat-transfer portion are helical, and wherein the portions of the wall of the balloon between the first heat transfer portion and the second heat-transfer portion are thermally insulated. 2. The cryotherapeutic device of claim 1 wherein the balloon comprises: a first wall portion having a first average thickness; and a second wall portion having a second average thickness, wherein the second average thickness is greater than the first average thickness. 3. The cryotherapeutic device of claim 1 , further comprising an occlusion member spaced apart proximally from the applicator, wherein the occlusion member has a low-profile collapsed state and an expanded deployed state, and wherein the occlusion member is configured to fully occlude the renal artery or renal ostium proximal of the treatment site when the occlusion member is in the expanded deployed state. 4. The cryotherapeutic device of claim 3 , further comprising a filler lumen extending along the length of the elongate shaft, wherein the filler lumen is fluidly connected to the occlusion member, and wherein the occlusion member is fluidly separate from the supply lumen. 5. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: the cooling assembly has a longitudinal axis centered in a plane that transects the cooling assembly and intersects a given one of the orifices; and when the cooling assembly is in the expanded deployed state, a distance in the plane from the longitudinal axis to the given orifice is not less than 20% of a distance in the plane from the longitudinal axis to a given portion of the wall of the balloon toward which the given orifice directs expanding refrigerant. 6. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: the cooling assembly has a longitudinal axis centered in a plane that transects the cooling assembly and intersects a given one of the orifices; and when the cooling assembly is in the expanded deployed state, a distance in the plane from the longitudinal axis to the given orifice is not less than 60% of a distance in the plane from the longitudinal axis to a given portion of the wall of the balloon toward which the given orifice directs expanding refrigerant. 7. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: the cooling assembly has a longitudinal axis centered in a plane that transects the cooling assembly and intersects a given one of the orifices; and the given orifice is spaced apart more than 0.1 mm from the longitudinal axis. 8. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: the cooling assembly has a longitudinal axis centered in a plane that transects the cooling assembly and intersects a given one of the orifices; and the given orifice is spaced apart more than 1 mm from the longitudinal axis. 9. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: the cooling assembly has a longitudinal axis centered in a plane that transects the cooling assembly and intersects a given one of the orifices; and the given orifice is spaced apart more than 0.1 mm from the balloon when the cooling assembly is in the expanded deployed state. 10. The cryotherapeutic device of claim 1 wherein the supply lumen comprises a plurality of orifices extending along the helical portion, and wherein: the cooling assembly has a longitudinal axis centered in a plane that transects the cooling assembly and intersects a given one of the orifices; and the given orifice is spaced apart more than 4 mm from the balloon when the cooling assembly is in the expanded deployed state. 11. The cryotherapeutic device of claim 1 , further comprising a thermally-insulative member at the second heat-transfer portion. 12. The cryotherapeutic device of claim 1 wherein, during operation, the first and second heat-transfer portions have heat-transfer rates sufficient to cause therapeutically-effective renal nerve modulation. 13. The cryotherapeutic device of claim 1 wherein, during operation, portions of the wall of the balloon between the first heat-transfer portion and the second heat-transfer portion have heat-transfer rates insufficient to cause therapeutically-effective renal nerve modulation.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10842547B2 cover?
Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatm…
Who is the assignee on this patent?
Medtronic Ardian Luxembourg
What technology area does this patent fall under?
Primary CPC classification A61B18/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).